A Curious Case of Acute STEMI in a Young Patient; Things are Not Always What They Seem

Main Article Content

Elif Vraynko
Biljana Zafirovska
Biljana Dimitrovska
I. Bede
S. Tomeski
Nela Kostova
Magdalena Otljanska


BACKGROUND: Acute myocardial infarction (MI) is a rare occurrence in patients under 40 years of age without positive family history for coronary artery disease (CAD). Genetic conditions as inherited thrombophilia can lead to a hypercoagulable state, resulting in thromboembolic events and arterial thrombosis.

CASE SUMMARY: We present a case of a 35-year-old male patient who presented to the emergency room with an inferior MI after a strenuous cycling exercise. An urgent coronary angiography showed thrombotic formations in the right coronary artery without atherosclerotic plaques. Plain old balloon angioplasty and thrombus aspiration were performed, which was followed by GP IIb/IIIa inhibitor infusion and unfractionated heparin for 24 h. From past medical history, the patient had COVID-19 like symptoms 20 days before the event and had his first dose of anti- COVID vaccine 2 weeks prior. After additional testing, molecular genetic analysis results revealed the patient to be heterozygous for factor V Leiden (FVL) and homozygous for methylenetetrahydrofolate reductase C677T gene mutation. The patient was discharged on direct oral anticoagulant and antiplatelet therapy. After 1-year follow-up, he had no symptoms or recurrent cardiovascular events.

CONCLUSION: Inherited thrombophilia is а significant risk factor for CAD and performing genetic testing in younger patients with a cardiovascular  event and plays an important role for adequate treatment and prophylaxis from recurrent complications. The use of oral anticoagulation for prophylaxis is shown to be effective in these patients. However, further studies are needed to prove their exact role and duration of treatment.


Download data is not yet available.

Article Details

How to Cite
Vraynko E, Zafirovska B, Dimitrovska B, Bede I, Tomeski S, Kostova N, Otljanska M. A Curious Case of Acute STEMI in a Young Patient; Things are Not Always What They Seem. SEE J Cardiol [Internet]. 2023 Jun. 30 [cited 2023 Dec. 2];4(1):36-9. Available from: https://seejca.eu/index.php/seejca/article/view/6047
General Cardiology


Bhardwaj R, Kandoria A, Sharma R. Myocardial infarction in young adults-risk factors and pattern of coronary artery involvement. Niger Med J. 2014;55(1):44-7. https://doi.org/10.4103/0300-1652.128161 PMid:24970969

Zafirovska B, Otljanska M, Kedev S, Petkoska D. Risk factor distribution and long-term outcomes in young patients undergoing percutaneous coronary intervention in Macedonia. Acta Clin Croat. 2019;58(4):583-9. https://doi.org/10.20471/acc.2019.58.04.03 PMid:32595241

Egred M, Viswanathan G, Davis GK. Myocardial infarction in young adults. Postgrad Med J. 2005;81(962):741-5. https://doi.org/10.1136/pgmj.2004.027532 PMid:16344295

Bhisma MS, Pratanu I, Intan RE, Alkaff FF. Inherited thrombophilia transpires with severe coronary arterial thrombosis in wide range of age backgrounds: A report of 3 cases. Ann Med Surg (Lond). 2022;78:103730. https://doi.org/10.1016/j.amsu.2022.103730 PMid:35600193

Albagoush SA, Koya S, Chakraborty RK, Schmidt AE. Factor V Leiden mutation. National library of medicine. In: StatPearls. Treasure Island, FL: StatPearls. Available from: https://www. ncbi.nlm.nih.gov/books/NBK534802 [Last accessed on 2022 Apr 04].

Zaghloul A, Iorgoveanu C, Desai A, Balakumaran K, Chen K. Methylenetetrahydrofolate reductase polymorphism and premature coronary artery disease. Cureus. 2019;11(6):e5014. https://doi.org/10.7759/cureus.5014 PMid:31497444

Modin D, Claggett B, Sindet-Pedersen C, Lassen MC, Skaarup KG, Jensen JU, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142(21):2080-2. https://doi.org/10.1161/CIRCULATIONAHA.120.050809 PMid:33054349

Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST-Segment elevation in patients with Covid-19 - a case series. N Engl J Med. 2020;382(25):2478-80. https://doi.org/10.1056/NEJMc2009020 PMid:32302081

Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799-801. https://doi.org/10.1001/jama.2020.13372 PMid:32702090

Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583-90. https://doi.org/10.1038/s41591-022-01689-3

Murray NP, Fuentealba C, Reyes E, Salazar A. Renal infarction associated with asymptomatic Covid-19 infection. Hematol Transfuse Cell Ther. 2021;43(3):353-6. https://doi.org/10.1016/j.htct.2021.03.008 PMid:34027306

Bereczky Z, Balogh L, Bagoly Z. Inherited thrombophilia and the risk of myocardial infarction: Current evidence and uncertainties. Kardiol Pol. 2019;77(4):419-29. https://doi.org/10.33963/KP.14804 PMid:31025650

Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, et al. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367(9511):651-8. https://doi.org/10.1016/S0140-6736(06)68263-9 PMid:16503463

Dowaidar M, Settin A. Risk of myocardial infarction related to factor V Leiden mutation: A meta-analysis. Genet Test Mol Biomarkers. 2010;14(4):493-8. https://doi.org/10.1089/gtmb.2010.0017 PMid:20642359

Chiasakul T, De Jesus E, Tong J, Chen Y, Crowther M, Garcia D, et al. Inherited thrombophilia and the risk of arterial ischemic stroke: A systematic review and meta-analysis. J Am Heart Assoc. 2019;8(9):e012877. https://doi.org/10.1161/JAHA.119.012877 PMid:31549567

Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ.

;325(7374):1202. https://doi.org/10.1136/bmj.325.7374.1202 PMid:12446535

Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies. Am Heart J. 2003;146(6):948-57. https://doi.org/10.1016/S0002-8703(03)00519-2 PMid:14660985

Badulescu OV, Sirbu PD, Filip N, Bordeianu G, Cojocaru E, Budacu CC, et al. Hereditary thrombophilia in the era of COVID-19. Healthcare (Basel). 2022;10(6):993. https://doi.org/10.3390/healthcare10060993 PMid:35742044

Elbadry MI, Tawfeek A, Abdellatif MG, Salama EH, Abudeif A, Mahmoud H, et al. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia. Br J Haematol. 2022;196(4):902-22. https://doi.org/10.1111/bjh.17986 PMid:34888860

Most read articles by the same author(s)